New
Latest update 22/03/2020 11:05 PST (Study released on BioArxiv for therapy Favipiravir with Tocilizumab

Together against COVID-19

The Corona virus outbreak is a unique global crisis. Everyone is committed to support doctors and patients around the world with fast access to medicines, tests and resources available.

Everyone together against COVID-19.

Contributing

Global Supply 24/7

Together with our contributors, we support you in globally accessing medicines you urgently need 24/7.

Doctor, Pharmacist and Patients

We help patients and healthcare professionals get the best possible medicines they need in their fight against COVID-19.

Fast & secured delivery

Every medicine is sourced directly from the manufacturer and delivered to you quickly and safely.

People before profit

Everyone.org is
supported by the
Bill & Melinda Gates Foundation

Perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa.

The latest updates

Healthcare researchers and scientists from all over the world are working around the clock to find a COVID-19 cure. We are constantly tracking the latest Randomized and non-Randomized Clinical Trials (RCTs) that are taking place globally in order to keep you updated with the latest COVID-19 related news. Here are some of the recently published articles.
"A study in China reported that chloroquine treatment of COVID-19 patients had clinical and virologic benefit versus a comparison group, and chloroquine"
Centre for Disease Control and Prevention
United States
Remdesivir is an investigational intravenous drug with broad antiviral activity that inhibits viral replication through premature termination of RNA transcription
Organization
Someone else
"A National Institutes of Health (NIH)-sponsored adaptive double-blinded, placebo-controlled trial of remdesivir versus placebo in COVID-19 patients with pneumonia"
Study name
Organization

Explore the medicines
available today

View Medicines